World's Best Scientists 2026 revealed!
Biomarkers in Medicine
H-index 12

Biomarkers in Medicine

1752-0363

Published by: Future Medicine Ltd,

https://www.futuremedicine.com/loi/bmm

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 2458 59 51 9

Additional Metrics

Number of Best Scientists*: 104
Documents by Best Scientists*: 94
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 59
SCIMAGO SJR: 0.493
Impact Factor: 2.1

Overview

Top Research Topics at Biomarkers in Medicine?

Biomarkers in Medicine is organized to address concerns in the fields of Internal medicine, Biomarker (medicine), Oncology, Disease and Bioinformatics. Biomarkers in Medicine tackles research in Heart failure as part of the general discipline of Internal medicine, however, it also discusses concepts in In patient. While work presented in Biomarkers in Medicine provided substantial information on Biomarker (medicine), it also covered topics in Cancer research, Immunology, Intensive care medicine, Pathology and microRNA.

The Oncology works featured in Biomarkers in Medicine incorporate elements from Meta-analysis and Cancer, Colorectal cancer, Breast cancer. It connects the study in Bioinformatics with the closely related area of Biomarker discovery. Myocardial infarction and Coronary artery disease are Cardiology topics of special interest in it.

  • Internal medicine (48.41%)
  • Biomarker (medicine) (29.67%)
  • Oncology (19.10%)

What are the most cited papers published in the journal?

  • Exosomes: the future of biomarkers in medicine. (283 citations)
  • Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies. (279 citations)
  • Current developments in salivary diagnostics (258 citations)

Research areas of the most cited articles at Biomarkers in Medicine:

The most cited articles investigate areas of study like Biomarker (medicine), Disease, Bioinformatics, Pathology and Internal medicine. Cerebrospinal fluid, Immunology and Intensive care medicine are some topics wherein Disease research discussed in the most cited publications has an impact. The journal publications address concerns in Internal medicine which are intertwined with other disciplines, such as Diabetes mellitus, Endocrinology, Oncology, Cardiology and Gastroenterology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Gene

The previous edition focused in particular on these issues:

Biomarkers in Medicine explores disciplines such as Internal medicine, Oncology, Biomarker (medicine), Gastroenterology and Cardiology. Aside from Internal medicine, Biomarkers in Medicine also covered works in the field of In patient. The overlapping concepts between Proportional hazards model and Survival analysis are the key highlights of Oncology study.

In addition to Biomarker (medicine) research, Biomarkers in Medicine aims to explore topics under Area under the curve and Disease. Disease research presented in the journal encompasses a variety of subjects, including Pathogenesis and Intensive care medicine. The work on Cancer tackled in it brings together disciplines like Malignancy and Overall survival.

The most cited articles from the last journal are:

  • The diagnostic value of plasma exosomal hsa_circ_0070396 for hepatocellular carcinoma. (3 citations)
  • HER2 in metastatic colorectal cancer: a new to target to remember. (3 citations)
  • Clinical implications of placenta-derived angiogenic/anti-angiogenic biomarkers in pre-eclampsia. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Biomarkers in Medicine (based on the number of publications) are:

  • Henrik Zetterberg (20 papers) absent at the last edition,
  • Jens P. Goetze (19 papers) absent at the last edition,
  • Scott A. Waldman (15 papers) published 2 papers at the last edition,
  • Dimitrios H Roukos (14 papers) absent at the last edition,
  • Charles J. Rosser (10 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Biomarkers in Medicine (based on the number of publications) are:

  • Mayo Clinic (28 papers) published 1 paper at the last edition the same number as at the previous edition,
  • University of Copenhagen (23 papers) absent at the last edition,
  • National Center for Toxicological Research (22 papers) absent at the last edition,
  • University of Health Sciences Antigua (21 papers) published 6 papers at the last edition, 1 less than at the previous edition,
  • Thomas Jefferson University (18 papers) published 2 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.79% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 10.08% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.53% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.50% of all publications and 65.89% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Growth in Medicine Biomarker Research

While we explore the exciting world of biomarkers in medicine, it's also worth highlighting the various career opportunities and growth trajectory this field offers. Biomarker research is an emerging discipline that offers promising career growth for individuals interested in healthcare and cutting-edge biomedical research. This field integrates various sub-disciplines such as internal medicine, oncology, bioinformatics, and more, creating the potential for a diverse range of specializations. A key role within this field is that of a Nurse Practitioner specializing in biomarker research. This role combines the patient-facing care duties of a nurse with the advanced research capabilities of a scientist. In these roles, professionals use biomarkers to diagnose and manage diseases. If you're in Idaho, you might be interested in learning how to be a nurse practitioner in Idaho. Job opportunities also extend to roles like clinical research associate, laboratory technician, bioinformatics specialist, or a specialist in oncology, cardiology, or internal medicine dedicated to biomarker research. Each role demands a deep understanding of biomarkers in the diagnosis and treatment of various diseases and conditions. This dynamic field is primed for exponential growth due to the continuous advancements in genetics, genomics, and personalized medicine. Professionals in this domain can expect intriguing research opportunities, competitive salaries, and the satisfaction of contributing to a breakthrough in medical sciences. Overall, the field of biomarkers in medicine offers an exciting blend of innovation, challenge, and service – a promising career path for anyone passionate about healthcare and advanced biomedical research.

Top Publications

  • The diagnostic value of plasma exosomal hsa_circ_0070396 for hepatocellular carcinoma.

    Lihua Lyu;Wenjing Yang;Jiayi Yao;Hao Wang

    (2021)
    37 Citations
  • The Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.

    (2022)
    24 Citations
  • Circular RNAs: new genetic tools in melanoma.

    Jamal Hallajzadeh;Elaheh Amirani;Hamed Mirzaei;Rana Shafabakhsh

    (2020)
    18 Citations
  • Inflammatory markers and incident heart failure in older men: the role of NT-proBNP.

    Douglas Gj McKechnie;A Olia Papacosta;Lucy T Lennon;Paul Welsh

    (2021)
    15 Citations
  • Role of collagen turnover biomarkers in the noninvasive assessment of myocardial fibrosis: an update.

    Carina Ureche;Alina-Elena Nedelcu;Radu A Sascău;Cristian Stătescu

    (2020)
    12 Citations
  • Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a Phase II trial.

    Kathryn R Wagner;Michaela Guglieri;Shashi K Ramaiah;Lawrence Charnas

    (2021)
    11 Citations
  • Tubular injury and cell-cycle arrest biomarkers to predict acute kidney injury in noncritically ill children receiving aminoglycosides.

    Hayton Chui;Jillian Caldwell;Mariya Yordanova;Vedran Cockovski

    (2020)
    10 Citations
  • Circular RNA as a potential diagnostic and/or therapeutic target for endometriosis.

    Parisa M Dana;Mona Taghavipour;Hamed Mirzaei;Bahman Yousefi

    (2020)
    10 Citations
  • Application of a machine learning-driven, multibiomarker panel for prediction of incident cardiovascular events in patients with suspected myocardial infarction.

    Johannes T Neumann;Nils A Sörensen;Tanja Zeller;Craig A Magaret

    (2020)
    10 Citations
  • Clinical potential of long non-coding RNA LINC01133 as a promising biomarker and therapeutic target in cancers.

    (2022)
    9 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA, exploring related online degrees can open up diverse career opportunities beyond traditional medical practice. Advanced programs like an online masters in healthcare management help students gain leadership skills crucial for managing healthcare facilities and improving patient care systems.

Healthcare professionals looking to specialize might consider psychiatric nursing. The psych nurse practitioner programs provide focused training to address mental health issues, filling a critical gap in today’s healthcare landscape.

Nutrition plays a foundational role in overall health, making an online nutrition degree an excellent choice for those wanting to influence wellness through dietetics, community health, or clinical nutrition counseling.

For students aiming to merge business acumen with healthcare expertise, pursuing an mba healthcare management online offers a flexible and affordable path to executive roles in hospitals, insurance companies, and health organizations.

Best Scientists Contributing to This Journal